First Eagle Investment Management LLC Sells 73,302 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

First Eagle Investment Management LLC trimmed its holdings in AdaptHealth Corp. (NASDAQ:AHCO) by 7.9% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 857,136 shares of the company’s stock after selling 73,302 shares during the quarter. First Eagle Investment Management LLC owned about 0.64% of AdaptHealth worth $8,160,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of AHCO. Assetmark Inc. bought a new stake in AdaptHealth in the 4th quarter worth about $28,000. Blue Trust Inc. grew its stake in shares of AdaptHealth by 24.1% during the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after purchasing an additional 1,115 shares during the period. Quarry LP grew its stake in shares of AdaptHealth by 4,596.9% during the 3rd quarter. Quarry LP now owns 5,965 shares of the company’s stock valued at $67,000 after purchasing an additional 5,838 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its stake in shares of AdaptHealth by 15.4% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after purchasing an additional 1,690 shares during the period. Finally, CIBC Asset Management Inc bought a new stake in shares of AdaptHealth during the 3rd quarter valued at about $122,000. 82.67% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

AHCO has been the topic of a number of analyst reports. Truist Financial lifted their price objective on AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a research report on Wednesday, February 26th. Canaccord Genuity Group lifted their price objective on AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a research report on Wednesday, February 26th. Robert W. Baird lifted their price objective on AdaptHealth from $14.00 to $16.00 and gave the company an “outperform” rating in a research report on Thursday, February 27th. UBS Group lowered their price objective on AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Finally, Royal Bank of Canada lifted their price objective on AdaptHealth from $11.00 to $14.00 and gave the company an “outperform” rating in a research report on Wednesday, February 26th. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $13.80.

AdaptHealth Stock Down 0.1 %

NASDAQ AHCO opened at $9.60 on Friday. The stock’s 50 day moving average is $10.02 and its 200 day moving average is $10.23. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. AdaptHealth Corp. has a 12 month low of $8.35 and a 12 month high of $11.90. The stock has a market cap of $1.29 billion, a PE ratio of -5.82, a P/E/G ratio of 1.08 and a beta of 1.30.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.